The materials associated with these meetings are intended healthcare professionals and may refer to drug classes where Teva has a product and/or Teva products. This educational site for healthcare professionals has been initiated and funded by Teva. Prescribing Information is available here.

Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com.

On Demand Recordings

Head Start Annual Meeting

This video collection is from Head Start's Annual Meeting, held in June 2024

Exploring the current headache landscape- what do the new guidelines mean for patient practice?

Discuss what the new guidelines mean for patient practice with Dr Jane Anderson

Click to go to video page

Exploring predictors of response to anti-CGRP monoclonal antibodies: latest clinical evidence

Explore the latest clinical data with Professor Cristina Tassorelli

Click to go to video page

Behavioural change for migraine prevention

Professor Ivo Vlaev discusses the application of behavioural science in migraine prevention

Click to go to video page

Next event

Head Start Events in 2025

We're finalising our event and webinar schedule for 2025

To ensure you receive information about future events, register your email with Teva.

Back to Head Start Hub

Date of preparation: January 2025

Reference: D: MIG-GB-00411 (V4.0) / T: MIG-GB-00412 (V4.0) / M: MIG-GB-00413 (V4.0)

This educational site for healthcare professionals has been initiated and funded by Teva.

Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX
+44 (0) 1977 628500 | www.tevauk.com | Copyright © 2024 Teva UK Limited